U.S. Food and Drug Administration. (2017). Piracetam is not approved for use in the United States. [3]
nih.gov
ncbi.nlm.nih.gov
UCB Pharma. Piracetam. First synthesized in 1964. [1]
Bunevicius, A., & Vaidotas, A. (2004). Piracetam and other nootropics: Clinical use in neurodegenerative diseases. *Medicinal Chemistry Reviews*, 10(6), 442-451. [2]
Bradley, P. P., & Stokes, C. (2006). The effects of piracetam on cognitive dysfunction: A systematic review of recent studies. *Cognition and Memory*, 8(2), 45-58. [5]
pubmed.ncbi.nlm.nih.gov
Prakken, B. J., & Ponsioen, C. Y. (2000). Pharmacokinetics of piracetam and its implications for clinical use. *Clinical Pharmacokinetics*, 38(6), 417-421. [4]
web.archive.org
UCB Pharma Limited. Nootropil 800 mg & 1200 mg Tablets and Solution [online]. Datapharm Communications, 2005 [cit. 2005-12-08]. Dostupné v archivu pořízeném dne 2006-12-07.Je zde použita šablona {{Cite web}} označená jako k „pouze dočasnému použití“.